UBS Group’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Buy |
|
|||||
|
2025
Q1 | $59.4K | Sell |
|
|||||
|
2024
Q4 | $553K | Buy |
|
|||||
|
2024
Q3 | $150K | Buy |
|
|||||
|
2024
Q2 | $123K | Sell |
|
|||||
|
2024
Q1 | $444K | Sell |
|
|||||
|
2023
Q4 | $425K | Buy |
|
|||||
|
2023
Q3 | $287K | Buy |
|
|||||
|
2023
Q2 | $487K | Sell |
|
|||||
|
2023
Q1 | $522K | Sell |
|
|||||
|
2022
Q4 | $1.43M | Buy |
|
|||||
|
2022
Q3 | $149K | Buy |
|
|||||
|
2022
Q2 | $34K | Buy |
|
|||||
|
2022
Q1 | $25K | Sell |
|
|||||
|
2021
Q4 | $112K | Buy |
|
|||||
|
2021
Q3 | $4K | Buy |
|